Plain-English translation of NCT06907836 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that looks back at medical records of patients who were diagnosed with transthyretin cardiac amyloidosis—a rare condition where abnormal proteins build up in the heart and damage its function. Researchers at a hospital in France want to understand this condition better by studying what happened to patients who were treated in their internal medicine department between 2013 and 2023. By learning more about how this disease develops and progresses, doctors hope to improve care and outcomes for future patients.
For a long time, this heart condition was missed or diagnosed too late because doctors didn't have good ways to spot it early and there weren't effective treatments available. Now that better treatments exist and diagnosis is improving, doctors need to understand how many people have this condition, how it affects them, and what happens to patients over time—especially those treated in general internal medicine rather than just cardiology specialists.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, which means researchers will review your existing medical records from your hospital visits and care—you won't need to attend new appointments or take new medications. The study simply involves allowing the hospital to use information from your past medical history, test results, and heart imaging to help researchers understand how this condition affects patients and how they respond to treatment over time.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France